Subscribe
shutterstock_1725090718_michael_vi
Michael Vi / Shutterstock.com
6 April 2021MedtechAlex Baldwin

Moldex-Metric hits Honeywell with false advertising suit

Honeywell has been targeted in a recent complaint from competitor Moldex-Metric over a newly-launched “antimicrobial” earplug dispenser, which Moldex claims is falsely advertised.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
CBD retailer sues over rival’s ‘false, disparaging’ TM use
15 February 2021   Cannabidiol retailer cbdMD is suing rival Majik Medicine over the latter’s use of the ‘CBD MD’ trademark, claiming it is confusing consumers.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Americas
CBD retailer sues over rival’s ‘false, disparaging’ TM use
15 February 2021   Cannabidiol retailer cbdMD is suing rival Majik Medicine over the latter’s use of the ‘CBD MD’ trademark, claiming it is confusing consumers.

More on this story

Americas
CBD retailer sues over rival’s ‘false, disparaging’ TM use
15 February 2021   Cannabidiol retailer cbdMD is suing rival Majik Medicine over the latter’s use of the ‘CBD MD’ trademark, claiming it is confusing consumers.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott